top of page


MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer
Expansion of 2021 clinical supply agreement for Phase 2 clinical trial Next stage of trial to further assess efficacy of THIO in third...


Precision Livestock Technologies to Present at 2024 Texas A&M Beef Cattle Short Course
CEO Andrew McKenzie Presenting on “Data-Driven Feeding: Artificial Intelligence and Machine Vision to Improve Cattle Intake” DALLAS, Aug....


MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
THIO’s favorable disease control and overall response rates exceed reported standard-of-care data in third line treatment June 04, 2024...
Press
bottom of page
